More FDA woes for Hospira

20-12-2013 Crain's Chicago BusinessComments (0)


The Food and Drug Administration has identified nearly two dozen problems at a Hospira Inc. drug manufacturing plant in India that the Lake Forest company says are related to “processes and procedures.” The agency on Dec. 10 inspected the facility in ...

Read more on Crain's Chicago Business

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top